Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Joint sensory nerve endings, specifically nociceptors, are specialized peripheral neurons that innervate joint structures such as the capsule, ligaments, and synovium to detect noxious stimuli (Schaible, 2014). These endings express a variety of molecular transducers, including transient receptor potential (TRP) channels, acid-sensing ion channels (ASICs), and voltage-gated sodium channels, which convert mechanical and chemical signals into action potentials (McDougall, 2006). In chronic joint diseases like osteoarthritis, these nociceptors become sensitized by inflammatory mediators such as nerve growth factor (NGF) and prostaglandins, leading to increased pain sensitivity or hyperalgesia (Miller et al., 2014). Pharmacological targeting of these sites involves the use of local anesthetics to block signal transmission, capsaicin to desensitize receptors, or monoclonal antibodies to inhibit sensitizing factors like NGF. However, profound inhibition of these nociceptive pathways can lead to safety concerns, including the risk of accelerated joint destruction due to the loss of protective pain feedback.
Inhibition of voltage-gated sodium channels to block nerve conduction, desensitization of TRPV1 channels, and neutralization of nerve growth factor (NGF) to prevent peripheral sensitization.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Joint sensory nerve nociceptor.